UTHRUnited Therapeutics Corporation

$24B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+21.9% YoY

Gross Profit

$986M88.3% margin

Operating Income

$292M26.2% margin

Net Income

$175M15.6% margin

EPS (Diluted)

$3.28

Cash Flow

Operating Cash Flow

$425M

Free Cash Flow

$393M

Stock-Based Comp.

$321M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$783M

Stockholders' Equity

$1.3B

Cash & Equivalents

$279M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$916M	+21.9%
Gross Profit	$986M	$797M	+23.7%
Operating Income	$292M	$422M	-30.6%
Net Income	$175M	$304M	-42.7%

UTHR FY 2013 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena